Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
1 other identifier
interventional
32
1 country
2
Brief Summary
The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2023
CompletedFirst Submitted
Initial submission to the registry
September 13, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2023
CompletedJanuary 19, 2024
January 1, 2024
6 months
September 13, 2023
January 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Transdermal optical imaging (TOI) signals
Blood flow patterns of the face obtained from the video camera on a smart phone
GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day. For EXERCISE, pre and post exercise session allowing for 30 minute cool down period.
Standard measurements of hydration status
Body mass change, urine specific gravity, urine color (1-8 scale), and visual analogue scale to indicate thirst (1=not thirsty at all to 7 very, very thirsty)
GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day. For EXERCISE, pre and post exercise sessions allowing for 30 minute cool down period.
Secondary Outcomes (16)
Demographics
At screening
Fitzpatrick scale
At screening
Mood scale
GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day
Dietary and fluid intake
24 hours prior to each visit through end of each study period.
EXERCISE only: Rate of perceived exertion (RPE)
Two 90 minute standard cycling exercise trials separated by approximately 3 to 7 days
- +11 more secondary outcomes
Study Arms (4)
GENPOP passive dehydration
EXPERIMENTAL24-hour data collection using a parallel design comparison of TOI blood flow patterns vs. reference methods of hydration status in 10 PEP employees.
EXERCISE without fluid replacement
EXPERIMENTALRandomized cross-over design in 15 moderately active non-employee participants. 90 minutes of standard cycling exercise trial in heat chamber. TOI signals will obtain blood flow patterns from the face to compare against reference methods of dehydration including body mass, urine specific gravity, urine color, and thirst.
GENPOP ad lib fluid intake
OTHER24-hour data collection using a parallel design comparison of TOI blood flow patterns vs. reference methods of hydration status in 10 PEP employees.
EXERCISE with fluid replacement
OTHERRandomized cross-over design in 15 moderately active non-employee participants. 90 minutes of standard cycling exercise trial in heat chamber. TOI signals will obtain blood flow patterns from the face to compare against reference methods of dehydration including body mass, urine specific gravity, urine color, and thirst.
Interventions
Over 24-hours
90-min standard cycling exercise trial in heat chamber
90-min standard cycling exercise trial in heat chamber
Eligibility Criteria
You may qualify if:
- Subject is male or female
- If female, subject is not pregnant
- For GENPOP study subject is 18-65 years of age, inclusive
- For EXERCISE study subject is 18-50 years of age, inclusive
- Subject is moderately-trained (engages in moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 1 hour at a time (EXERCISE session participants only)
- Subject does not smoke (or has quit for at least 6 months)
- Subject is not taking medication that may interfere with the study
- Subject has no health conditions that would prevent completion of the trial as indicated on the general health questionnaire (GHQ)
- Subject is willing to avoid alcohol consumption 24 hours prior to visit(s)
- Subject is willing to fast overnight (\~8-12 hours)
- For GENPOP, subject is willing to refrain from vigorous exercise for 48 hours
- For EXERCISE, subject is willing to refrain from vigorous exercise for 24 hours prior to study visits
- Subject is willing to eat the exact same food the day prior to each visit to the laboratory
- Subject is willing to avoid wearing makeup to the study session
- Subject is willing to shave facial hair if predetermined during the informed consent session it will interfere with TOI measurement
- +2 more criteria
You may not qualify if:
- Subject has participated in a clinical trial within the past 30 days
- Subject has participated in any PepsiCo trial within past 6 months
- Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
- Subject is allergic to alcohol or facial cleansing wipes
- Subject has a history of anaphylaxis or severe allergic reactions
- Subjects has a health condition or is taking medication that can be worsened by fluid restriction
- Subject has asthma or other condition which breathing can become labored during exercise (EXERCISE session participants only)
- Male subjects with a VO2max \< 42 ml/kg/min and females with a VO2max \< 38 ml/kg/min (EXERCISE session participants only)
- Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
PepsiCo R&D, Gatorade Sports Science Institute
Valhalla, New York, 10595, United States
PepsiCo R&D, Gatorade Sports Science Institute
Plano, Texas, 75024, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lindsay Baker, PhD
PepsiCo, Inc. Sports Science
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2023
First Posted
September 21, 2023
Study Start
May 8, 2023
Primary Completion
November 15, 2023
Study Completion
November 15, 2023
Last Updated
January 19, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share